Grade II astrocytomas are subgrouped by chromosome aberrations

Yuichi Hirose, Kenneth D. Aldape, Susan Chang, Kathleen Lamborn, Mitchel S. Berger, Burt G.F. Feuerstein

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Grade II astrocytoma is defined as a low-grade tumor, yet patients have a wide range of survival and tumors can quickly progress to high-grade astrocytoma/glioblastoma. Previous studies using comparative genomic hybridization (CGH) failed to demonstrate frequent copy number aberrations (CNA) in these tumors. This may be related to technical difficulties because infiltrating astrocytic tumors are often intermixed with normal brain tissue. We developed methods to exclude most normal tissue and use small amounts of DNA for CGH by microdissecting small regions of tumor from paraffin sections and amplifying extracted DNA using degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR). Using this method, we examined 30 grade II astrocytoma cases. We found CNA in 25 cases (83%), with a mean of two CNA per case. The most frequent CNA were gains on 7q (12 cases), 5p (5 cases), 9 (5 cases), and 19p (3 cases), and losses on 19q (7 cases), 1p (6 cases), and Xp (3 cases). Gain on 7q and losses on 1p/19q were mutually exclusive. This is the first report on the genetic characterization of low-grade astrocytomas using CGH from microdissected and formalin-fixed tissue. The comparatively large number of cases in this study allows us to suggest that these tumors are genetically subgrouped.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalCancer Genetics and Cytogenetics
Volume142
Issue number1
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Astrocytoma
Chromosome Aberrations
Comparative Genomic Hybridization
Neoplasms
DNA
Glioblastoma
Paraffin
Formaldehyde
Polymerase Chain Reaction
Survival
Brain

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Grade II astrocytomas are subgrouped by chromosome aberrations. / Hirose, Yuichi; Aldape, Kenneth D.; Chang, Susan; Lamborn, Kathleen; Berger, Mitchel S.; Feuerstein, Burt G.F.

In: Cancer Genetics and Cytogenetics, Vol. 142, No. 1, 01.04.2003, p. 1-7.

Research output: Contribution to journalArticle

Hirose, Yuichi ; Aldape, Kenneth D. ; Chang, Susan ; Lamborn, Kathleen ; Berger, Mitchel S. ; Feuerstein, Burt G.F. / Grade II astrocytomas are subgrouped by chromosome aberrations. In: Cancer Genetics and Cytogenetics. 2003 ; Vol. 142, No. 1. pp. 1-7.
@article{6f55292f6405480cb204ab101ac6fc88,
title = "Grade II astrocytomas are subgrouped by chromosome aberrations",
abstract = "Grade II astrocytoma is defined as a low-grade tumor, yet patients have a wide range of survival and tumors can quickly progress to high-grade astrocytoma/glioblastoma. Previous studies using comparative genomic hybridization (CGH) failed to demonstrate frequent copy number aberrations (CNA) in these tumors. This may be related to technical difficulties because infiltrating astrocytic tumors are often intermixed with normal brain tissue. We developed methods to exclude most normal tissue and use small amounts of DNA for CGH by microdissecting small regions of tumor from paraffin sections and amplifying extracted DNA using degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR). Using this method, we examined 30 grade II astrocytoma cases. We found CNA in 25 cases (83{\%}), with a mean of two CNA per case. The most frequent CNA were gains on 7q (12 cases), 5p (5 cases), 9 (5 cases), and 19p (3 cases), and losses on 19q (7 cases), 1p (6 cases), and Xp (3 cases). Gain on 7q and losses on 1p/19q were mutually exclusive. This is the first report on the genetic characterization of low-grade astrocytomas using CGH from microdissected and formalin-fixed tissue. The comparatively large number of cases in this study allows us to suggest that these tumors are genetically subgrouped.",
author = "Yuichi Hirose and Aldape, {Kenneth D.} and Susan Chang and Kathleen Lamborn and Berger, {Mitchel S.} and Feuerstein, {Burt G.F.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0165-4608(02)00791-4",
language = "English (US)",
volume = "142",
pages = "1--7",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Grade II astrocytomas are subgrouped by chromosome aberrations

AU - Hirose, Yuichi

AU - Aldape, Kenneth D.

AU - Chang, Susan

AU - Lamborn, Kathleen

AU - Berger, Mitchel S.

AU - Feuerstein, Burt G.F.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Grade II astrocytoma is defined as a low-grade tumor, yet patients have a wide range of survival and tumors can quickly progress to high-grade astrocytoma/glioblastoma. Previous studies using comparative genomic hybridization (CGH) failed to demonstrate frequent copy number aberrations (CNA) in these tumors. This may be related to technical difficulties because infiltrating astrocytic tumors are often intermixed with normal brain tissue. We developed methods to exclude most normal tissue and use small amounts of DNA for CGH by microdissecting small regions of tumor from paraffin sections and amplifying extracted DNA using degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR). Using this method, we examined 30 grade II astrocytoma cases. We found CNA in 25 cases (83%), with a mean of two CNA per case. The most frequent CNA were gains on 7q (12 cases), 5p (5 cases), 9 (5 cases), and 19p (3 cases), and losses on 19q (7 cases), 1p (6 cases), and Xp (3 cases). Gain on 7q and losses on 1p/19q were mutually exclusive. This is the first report on the genetic characterization of low-grade astrocytomas using CGH from microdissected and formalin-fixed tissue. The comparatively large number of cases in this study allows us to suggest that these tumors are genetically subgrouped.

AB - Grade II astrocytoma is defined as a low-grade tumor, yet patients have a wide range of survival and tumors can quickly progress to high-grade astrocytoma/glioblastoma. Previous studies using comparative genomic hybridization (CGH) failed to demonstrate frequent copy number aberrations (CNA) in these tumors. This may be related to technical difficulties because infiltrating astrocytic tumors are often intermixed with normal brain tissue. We developed methods to exclude most normal tissue and use small amounts of DNA for CGH by microdissecting small regions of tumor from paraffin sections and amplifying extracted DNA using degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR). Using this method, we examined 30 grade II astrocytoma cases. We found CNA in 25 cases (83%), with a mean of two CNA per case. The most frequent CNA were gains on 7q (12 cases), 5p (5 cases), 9 (5 cases), and 19p (3 cases), and losses on 19q (7 cases), 1p (6 cases), and Xp (3 cases). Gain on 7q and losses on 1p/19q were mutually exclusive. This is the first report on the genetic characterization of low-grade astrocytomas using CGH from microdissected and formalin-fixed tissue. The comparatively large number of cases in this study allows us to suggest that these tumors are genetically subgrouped.

UR - http://www.scopus.com/inward/record.url?scp=0345268776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345268776&partnerID=8YFLogxK

U2 - 10.1016/S0165-4608(02)00791-4

DO - 10.1016/S0165-4608(02)00791-4

M3 - Article

C2 - 12660025

AN - SCOPUS:0345268776

VL - 142

SP - 1

EP - 7

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -